Cyclo Therapeutics Inc

NASDAQ: CYTH
Share price (4/19/24): $1.16
Market cap (4/19/24): $33.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022 – amended

Prospectuses and Registrations Filter

Business combination disclosure

Business combination disclosure

Prospectus supplement

Details of business combination or exchange offer – amended

Details of business combination or exchange offer

Ownership Filter

Ostronic Francis Patrick

Toig Randall M.

Strattan Ce Rick

News Filter

Financial Statements or Exhibits

Material Modification to Rights of Security Holders, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Combined Company Operating as Cyclo Therapeutics With Primary Focus on Advancing Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1

Shareholder Vote Results

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC